Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Commentary: Substandard medicines are the priority for neglected tropical diseases.

Dorlo TP, Ravinetto RM, Beijnen JH, Boelaert M.

BMJ. 2012 Nov 14;345:e7518. doi: 10.1136/bmj.e7518. No abstract available.

PMID:
23152570
2.

How to achieve international action on falsified and substandard medicines.

Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M.

BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381. No abstract available.

PMID:
23149211
3.

European union has the falsified medicines directive.

Taaffe T.

BMJ. 2012 Dec 20;345:e8356. doi: 10.1136/bmj.e8356. No abstract available.

PMID:
23256949
4.
5.

We need to 'get real' about counterfeit medicine.

DeCola PR.

Int Nurs Rev. 2010 Sep;57(3):275-6. doi: 10.1111/j.1466-7657.2010.00842.x. No abstract available.

PMID:
20796051
7.
8.

Beef up international cooperation on counterfeits.

Shepherd M.

Nat Med. 2010 Apr;16(4):366. doi: 10.1038/nm0410-366.

PMID:
20376036
9.

Spurious and counterfeit drugs: a growing industry in the developing world.

Gautam CS, Utreja A, Singal GL.

Postgrad Med J. 2009 May;85(1003):251-6. doi: 10.1136/pgmj.2008.073213. Review.

PMID:
19520877
10.

[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].

Furman-Assaf S, Tamir O, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):470-5, 479. Hebrew.

PMID:
21465764
11.

Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.

't Hoen E, Pascual F.

J Public Health Policy. 2015 Nov;36(4):384-9. doi: 10.1057/jphp.2015.22. Epub 2015 Jul 16.

PMID:
26178809
12.

Ensuring global access to quality medicines: role of the US Pharmacopeia.

USP council of convention section on global public health.; USP council of experts international health expert committee.; USP regionalization team., Heyman ML, Williams RL.

J Pharm Sci. 2011 Apr;100(4):1280-7. doi: 10.1002/jps.22391. Epub 2010 Nov 24. Review.

PMID:
24081465
13.

Understanding and fighting the medicine counterfeit market.

D├ęgardin K, Roggo Y, Margot P.

J Pharm Biomed Anal. 2014 Jan;87:167-75. doi: 10.1016/j.jpba.2013.01.009. Epub 2013 Jan 11. Review.

PMID:
23384475
14.

Substandard/counterfeit antimicrobial drugs.

Kelesidis T, Falagas ME.

Clin Microbiol Rev. 2015 Apr;28(2):443-64. doi: 10.1128/CMR.00072-14. Review.

15.

Combatting substandard and falsified medicines: a view from Rwanda.

Binagwaho A, Bate R, Gasana M, Karema C, Mucyo Y, Mwesigye JP, Biziyaremye F, Nutt CT, Wagner CM, Jensen P, Attaran A.

PLoS Med. 2013;10(7):e1001476. doi: 10.1371/journal.pmed.1001476. Epub 2013 Jul 2. No abstract available.

16.

Fake medicines are everybody's business.

Benton D, Williamson L.

Aust Nurs Midwifery J. 2014 May;21(10):26. No abstract available.

PMID:
24941562
17.

WHO to set up international task force on counterfeit drugs.

Zarocostas J.

BMJ. 2006 Feb 25;332(7539):444. No abstract available.

18.

[The fight against counterfeit drugs].

Bruhn C.

Dtsch Med Wochenschr. 2013 Nov;138(47):2396-7. German. No abstract available.

PMID:
24369021
19.

Technology for combating counterfeit medicine.

Hall C.

Pathog Glob Health. 2012 May;106(2):73-6. doi: 10.1179/204777312X13419245939485. No abstract available.

20.

Pathogens and Global Health counterfeit medicine photo campaign.

[No authors listed]

Pathog Glob Health. 2012 May;106(2):72. doi: 10.1179/204777312X13419245939449. No abstract available.

Supplemental Content

Support Center